Actively Recruiting

Age: 18Years - 75Years
All Genders
NCT05403710

Botulinum Toxin Therapy in Hidradenitis Suppurativa

Led by University of Massachusetts, Worcester · Updated on 2025-09-15

20

Participants Needed

1

Research Sites

307 weeks

Total Duration

On this page

Sponsors

U

University of Massachusetts, Worcester

Lead Sponsor

H

Hidradenitis Suppurativa Foundation

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease Hidradenitis Suppurativa (HS). In this study, the investigators will test the hypothesis that inhibiting neuropeptide activity with botulinum toxin reduces pathogenic inflammation.

CONDITIONS

Official Title

Botulinum Toxin Therapy in Hidradenitis Suppurativa

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults between ages 18 and 75 years with established diagnosis of hidradenitis suppurativa (HS)
  • HS skin lesions of duration at least 1 year
  • HS skin lesions in at least two different body areas
Not Eligible

You will not qualify if you...

  • Age less than 18 years or greater than 75 years
  • Pregnant or breastfeeding
  • Neuromuscular disorder (ex. ALS, myasthenia gravis, Lambert-Eaton syndrome, myopathy)
  • Medical co-morbidity that is a relative contraindication to skin biopsy procedure (ex. end stage congestive heart failure or coagulopathy)
  • Active bacterial, fungal, or viral infection in the treatment area
  • Known hypersensitivity to botulinum toxin A preparations or any of their components (human albumin, saline, lactose, sodium succinate)
  • Prisoners
  • Adults unable to consent for themselves.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Massachusetts Chan Medical School

Worcester, Massachusetts, United States, 01605

Actively Recruiting

Loading map...

Research Team

S

Sarah K Whitley, MD PhD

CONTACT

M

Michelle Landry, MPH

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here